timeline crispr

Rasul, M.F., Hussen, B.M., Salihi, A. et al. Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy. Mol Cancer 21, 64 (2022). https://doi.org/10.1186/s12943-021-01487-4
Rasul, M.F., Hussen, B.M., Salihi, A. et al. Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy. Mol Cancer 21, 64 (2022). https://doi.org/10.1186/s12943-021-01487-4
0 Comments